Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

284
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
284
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

133
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
133
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

208
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
208
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

98
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
98
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.1K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension.

Nature communications·2026
Same author

Perspectives on C-Type Natriuretic Peptide in Cardiometabolic Disease.

Journal of the American Heart Association·2025
Same author

Finerenone ameliorates diabetic kidney disease exacerbated by deletion of natriuretic peptide/guanylyl cyclase-A signaling and dietary high-protein load.

Scientific reports·2025
Same author

Favorable 10-year outcomes of osteochondral autologous transplantation for spontaneous osteonecrosis of the knee following subchondral insufficiency fracture with optimal alignment correction.

Knee surgery & related research·2025
Same author

Frailty and Energy Intake Deficiency Reduce the Efficiency of Activities of Daily Living in Patients with Musculoskeletal Disorders: A Retrospective Cohort Study.

Nutrients·2025
Same author

Responses of B-type natriuretic peptide (BNP), mature BNP and proBNP to sacubitril/valsartan differs between responders and non-responders.

Open heart·2025

Related Experiment Video

Updated: Nov 3, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

332

Potential pitfalls when interpreting plasma BNP levels in heart failure practice.

Toshio Nishikimi1, Yasuaki Nakagawa2

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; Department of Medicine, Wakakusa Tatsuma Rehabilitation Hospital, Osaka, Japan.

Journal of Cardiology
|June 5, 2021
PubMed
Summary

B-type natriuretic peptide (BNP) measurements may include precursor proBNP, affecting accuracy. Understanding factors influencing BNP levels is crucial for effective heart failure management.

Keywords:
B-type (or brain) natriuretic peptideHeart failureN-terminal proBNPNeprilysin

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

453
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K

Related Experiment Videos

Last Updated: Nov 3, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

332
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

453
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • B-type natriuretic peptide (BNP) is synthesized by cardiac myocytes and released into circulation.
  • Neurohumoral factors, cytokines, ischemia, and pressure/volume overload enhance BNP gene expression, leading to precursor proBNP production.
  • Traditionally, proBNP was thought to be cleaved intracellularly into active BNP and inactive NT-proBNP before release.

Purpose of the Study:

  • To investigate the presence and implications of circulating uncleaved proBNP.
  • To highlight potential pitfalls in interpreting current BNP assay results.
  • To inform clinicians about factors affecting BNP values in heart failure management.

Main Methods:

  • Review of recent studies on proBNP processing and detection.
  • Analysis of factors influencing BNP assay cross-reactivity.
  • Examination of clinical variables affecting BNP interpretation.

Main Results:

  • Significant amounts of uncleaved proBNP circulate in the blood.
  • Commercial BNP assays can cross-react with proBNP, leading to overestimated BNP values (proBNP + BNP).
  • Numerous factors, including renal dysfunction, age, sex, atrial fibrillation, inflammation, hyperthyroidism, and specific medications, can alter BNP levels.

Conclusions:

  • Current BNP measurements may not solely reflect active BNP due to proBNP presence.
  • Accurate interpretation of BNP requires awareness of confounding factors that can overestimate or underestimate values.
  • Clinicians must consider these pitfalls for optimal heart failure patient management.